Conclusion: Patients with higher APACHE II
score, septic shock and multiorgan dysfunction syndrome at the time of admission in ICU had a higher mortality.
The abstract, which was published in the January Supplement of Critical Care Medicine and online, includes results from a pre-specified analysis from the ATHOS-3 Phase 3 study of GIAPREZATM in patients with high severity of illness, defined as an APACHE II
score greater than 30 or baseline MAP less than 65 mmHg, despite treatment with high-dose vasopressors.
Our multivariate analysis identified a higher APACHE II
score at onset (odds ratio [ OR ]: 1.
Prediction of outcome in patients with sepsis using C - reactive protein & APACHE II
3% in patients with a mean (standard deviation) APACHE II
score of 21.
The patient's age, gender, APACHE II
score, number of organ dysfunction, serum vitamin D level at ICU admission and outcomes were recorded.
PSS, APACHE II
and GCS: Effective clinical indices for estimating severity and predicting outcome of acute organophosphorus and carbamate poisoning.
There are several commonly used prognostic scoring systems for AP such as Ranson, Glasgow, APACHE II
(acute physiology and chronic health status), and BISAP (bedside index for severity in AP).
En cada paciente se analizaron las escalas APACHE II
y SOFA, al ingreso y al egreso, edad, sexo, diagnostico de ingreso, dias de hospitalizacion y el tipo de manejo recibido durante su estadia.
Moreover, APACHE II
and SOFA scores at first admission and 48 h were calculated.
The variables significantly predictive of mortality in patients with severe tetanus were APACHE II
score, continuous neuromuscular blockade, dysautonomia, and age.
Patients with VRE bacteraemia were found to have higher APACHE II
score compared to those with VSE BSIs (p=less than 0.